Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy
Status:
Withdrawn
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Antibiotics, such as daptomycin and vancomycin, may be effective in treating
bacteria in the blood. It is not yet known whether daptomycin is more effective than
vancomycin in treating bacteria in the blood in patients with neutropenia caused by
chemotherapy.
PURPOSE: This randomized clinical trial is studying daptomycin to see how well it works
compared with vancomycin in treating bacteria in the blood in patients with neutropenia
caused by chemotherapy.
Phase:
N/A
Details
Lead Sponsor:
Comprehensive Cancer Center of Wake Forest University Wake Forest University Health Sciences